[Radiation protection using a gaseous hypoxic mixture in oncological practice]. 1979

R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines

Studies on volunteers have shown that the gas hypoxic mixture containing 10% of oxygen and 90% of nitrogen (GHM-10) renders a protective action on the genetic apparatus of human skin cells but provides no protection of the peripheral blood leucocytes, which show the identical character of metabolic processes as neoplastic cells. Under clinically performed distant x-ray therapy for breast cancer the inhaling of GHM-10 was found to render the antiradiation protective action on different normal tissues (skin, subcellular connective tissue, muscle tissue, mammary gland tissue), but it fails to protect the tumor tissue and regional lymph nodes involved. The clinical observations were supported by pathomorphological examination of the operation material.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009584 Nitrogen An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D011835 Radiation Protection Methods and practices adopted to protect against RADIATION. Protection, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug

Related Publications

R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
January 1982, Radiobiologiia,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
January 1974, Radiobiologiia,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
January 1982, Radiobiologiia,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
August 1970, The Journal of small animal practice,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
September 1978, Meditsinskaia radiologiia,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
January 1982, Radiobiologiia,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
March 2008, Journal of the Air & Waste Management Association (1995),
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
May 1987, Zahnarztliche Praxis,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
November 1972, Schweizerische Monatsschrift fur Zahnheilkunde = Revue mensuelle suisse d'odonto-stomatologie,
R B Strelkov, and A Ia Chizhov, and A I Il'ina, and L E Kuznetsova, and E V Pines
January 1964, Der Offentliche Gesundheitsdienst,
Copied contents to your clipboard!